1[1]Jacobson TA, Schein JR, Williamson A, et al. Mazximizing the cost - effectiveness of lipid - lowering therapy[J ]. Arch Intem Med, 1998,158:1977 - 1989
2[2]Pedersen TR. Coronary artery disease:the Scandinavian Simvastatin Survival Study experience[J]. Am J Cardiol, 1998,82(10) :53 - 56
4[4]Pasterkamp G, Schoneveld AH, Van der Wal AC, et al.Inflammation of the atherosclerotic cap and shoulder of the plaque is a conmom and locally observed feature in unruptured plaques of femoral and coronary arteries[J ]. Arterioscler ThrombVasc Biol, 1999,19: 54 - 58
5[5]Crisby M, Nordin- Fresriksson G, Shah PK, et al.Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization [ J ]. Circulation,2001,2:181 - 188
9Bybee KA, Wright RS, Kopeck SL. Effect of early statin therapy after acute coronary syndromes : a concise review of the recent data. C ardiol Rev,2002,10 (5) :301-305.
10Winkler K, Schewe T, Putz G, et al. Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL- profiles [J]. Europ ean Journal of Clinical Investigation, 2009, 39 (6) : 463 - 470.
